UBS’s Chemed CHE Stock Holding History

UBS’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2.22M	Buy	21,615 +19,945	+1,194%	+$2.02M	﹤0.01%	2809
2014 Q2	$157K	Sell	1,670 -3,069	-65%	-$272K	﹤0.01%	5406
2014 Q1	$424K	Buy	4,739 +694	+17%	+$56.5K	﹤0.01%	4404
2013 Q4	$310K	Sell	4,045 -17,472	-81%	-$1.29M	﹤0.01%	4820
2013 Q3	$1.54M	Buy	21,517 +7,648	+55%	+$544K	﹤0.01%	2872
2013 Q2	$1M	Buy	+13,869	New	+$1.02M	﹤0.01%	3330

Other funds holding CHE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

UBS's CHE Position: Q3 2014 in Review

UBS increased its Chemed (CHE) stake by 1,194% in Q3 2014, buying an estimated $2.02M and bringing the position to 21,615 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

UBS first reported a position in CHE in Q2 2013 and has held it in 6 quarters since. 196 funds tracked by Wall St. Rank hold CHE as of Q3 2014.

UBS held 21,615 shares of Chemed worth $2.22M as of Q3 2014.
UBS bought 19,945 Chemed shares in Q3 2014, an estimated $2.02M.
Chemed made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2809 holding.
UBS first reported a position in Chemed in Q2 2013 and has held it in 6 quarters since.
196 funds tracked by Wall St. Rank held Chemed as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.